Insider sells 11,685 UniQure shares under 10b5-1 plan (QURE)

Rhea-AI Filing Summary

UniQure N.V. reported Section 144 sale notices for Ordinary Shares executed on 06/17/2026 pursuant to a 10b5-1 plan. The filing lists a sale method as stock option exercise and sale for 11,685 shares with cash proceeds. The excerpt also shows prior sales by Balachandran Madhavan on 06/11/2026 (1,993 shares) and 06/15/2026 (10,000 shares).

Insights

Securities Compliance Analyst

Routine Form 144 sale notices filed under a 10b5-1 plan.

The filing explicitly lists a stock option exercise and sale on 06/17/2026 for 11,685 shares, executed pursuant to a 10b5-1 plan. The cash‑flow treatment is shown as Cash for that transaction.

These entries are procedural notices required under Section 144; subsequent sale settlement details and exact proceeds received are not in the excerpt. Future regulatory filings may disclose settlement confirmations.

Insider Transactions Analyst

Transactions indicate supplier of liquidity via option exercise and sale; sequence shows multiple dated dispositions.

The excerpt lists two prior dispositions by Balachandran Madhavan: 1,993 shares on 06/11/2026 and 10,000 shares on 06/15/2026, with associated cash amounts $53,938.39 and $278,530.84 respectively. These amounts are presented as proceeds in the excerpt.

Timing and proportion relative to total holdings are not disclosed here; the filing is informational under Section 144.

Key Figures

Form date: 06/17/2026 Shares sold (06/17/2026): 11,685 shares Sale (06/11/2026): 1,993 shares +3 more

6 metrics

Form date 06/17/2026 date of the 11,685-share sale entry

Shares sold (06/17/2026) 11,685 shares stock option exercise and sale pursuant to a 10b5-1 plan

Sale (06/11/2026) 1,993 shares Balachandran Madhavan prior disposition

Proceeds (06/11/2026) $53,938.39 cash amount shown for 1,993-share sale

Sale (06/15/2026) 10,000 shares Balachandran Madhavan prior disposition

Proceeds (06/15/2026) $278,530.84 cash amount shown for 10,000-share sale

Key Terms

10b5-1 plan, Form 144, stock option exercise

3 terms

10b5-1 plan regulatory

"Stock option exercise and sale Pursuant to 10b5-1 plan"

A 10b5-1 plan is a pre-arranged strategy that allows company insiders to buy or sell their shares at predetermined times and prices, even while they are aware of confidential information. It acts like a scheduled appointment for trading, helping ensure transactions happen transparently and legally, which can reassure investors that trades are not based on insider knowledge.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

stock option exercise financial

"Securities To Be Sold ... Stock option exercise and sale"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Citigroup Global Markets, Inc 390 Greenwich Street New York NY 10013	11685	526462.64	63067485	06/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	06/17/2026	Stock option exercise and sale Pursuant to 10b5-1 plan	UniQure N.A.			11685	06/17/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Balachandran Madhavan PAASHEUVELWEG 25A AMSTERDAM P7 1105BP	ORDINARY SHARES	06/11/2026	1993	53938.39
Balachandran Madhavan PAASHEUVELWEG 25A AMSTERDAM P7 1105BP	ORDINARY SHARES	06/15/2026	10000	278530.84

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does UniQure (QURE) disclose in this Form 144?

The Form 144 discloses a stock option exercise and sale of 11,685 Ordinary Shares on 06/17/2026 executed pursuant to a 10b5-1 plan. The method is listed as Cash in the excerpt.

Who sold shares according to the filing for QURE?

The excerpt shows dispositions tied to Balachandran Madhavan with sales on 06/11/2026 (1,993 shares) and 06/15/2026 (10,000 shares). It also lists a 06/17/2026 sale of 11,685 shares under a 10b5-1 plan.

Were these sales part of a pre-arranged trading plan for QURE insiders?

Yes. The filing states the 06/17/2026 transaction was executed "Pursuant to 10b5-1 plan." The excerpt identifies the method as a stock option exercise and sale under that plan.

What proceeds are shown for previous Balachandran Madhavan sales?

The excerpt lists cash amounts: $53,938.39 for the 1,993-share sale on 06/11/2026 and $278,530.84 for the 10,000-share sale on 06/15/2026, as presented in the filing.